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SUMMARY
The target of rapamycin complex 1 (TORC1) is amas-
ter regulator of cell homeostasis, which promotes
anabolic reactions and synchronously inhibits cata-
bolic processes such as autophagy-mediated pro-
tein degradation. Its prime autophagy target is
Atg13, a subunit of the Atg1 kinase complex that
acts as the gatekeeper of canonical autophagy. To
study whether the activities of TORC1 and Atg1 are
coupled through additional, more intricate control
mechanisms than simply this linear pathway, we
analyzed the epistatic relationship between TORC1
and Atg1 by using quantitative phosphoproteomics.
Our in vivo data, combined with targeted in vitro
TORC1 and Atg1 kinase assays, not only uncover
numerous TORC1 and Atg1 effectors, but also sug-
gest distinct bi-directional regulatory feedback loops
and characterize Atg29 as a commonly regulated
downstream target of both TORC1 and Atg1. Thus,
an exquisitely multilayered regulatory network ap-
pears to coordinate TORC1 and Atg1 activities to
robustly tune autophagy in response to nutritional
cues.
INTRODUCTION
Cells continually adapt their metabolisms to meet nutrient and
energy requirements in response to environmental cues. The
target of rapamycin complex 1 (TORC1) signaling pathway plays
a key role in homeostatically regulating metabolism, cell growth,
and proliferation in response to nutrients and growth factors (Al-
bert and Hall, 2015; Saxton and Sabatini, 2017). Under condi-
tions that promote growth, the TORC1 protein kinase stimulates
protein synthesis and inhibits protein degradation via macroau-
tophagy (hereafter referred to as autophagy) (Dikic and Elazar,
2018; Hurley and Young, 2017; Kamada et al., 2010). Nutrient
limitation, in turn, results in TORC1 inhibition and, consequently,
the induction of autophagy, an evolutionarily conserved cata-
bolic process. Autophagy critically contributes to cell survival
through the recycling of macromolecular complexes and the
removal of nonfunctional and potentially toxic cellular compo-
nents by autophagosome-mediated vacuolar or lysosomal
degradation (Mizushima et al., 2011).
In yeast, more than 42 autophagy-related (Atg) proteins are
critical for vacuolar targeting of cytoplasmic components (Dikic
and Elazar, 2018). Several of them are part of ﬁve conserved pro-
tein complexes that form the core Atg machinery (Klionsky et al.,
2011): (1) the Atg1 kinase complex (comprising Atg1, Atg13,
Atg17, Atg29, and Atg31), which is critical for autophagy initia-
tion; (2) the class III phosphatidylinositol 3-kinase complex
(comprising Vps34, Vps15, Atg6, and Atg14), which generates
the lipid phosphatidylinositol-3-phosphate that serves as the
docking site for protein recruitment; (3) the Atg9 cycling system
(comprising Atg9, Atg2, and Atg18), which provides part of the
vesicles for autophagosome generation; (4) the Atg12 ubiqui-
tin-like conjugation system (comprising Atg7, Atg10, Atg5, and
Atg16), which generates the Atg12-Atg5/Atg16 complex that
has E3 enzyme-like activity toward Atg8; and (5) the Atg8 ubiqui-
tin-like conjugation system (comprising Atg7, Atg3, and Atg8),
which leads to the conjugation of Atg8 to phosphatidylethanol-
amine, with Atg8 being critical for phagophore expansion and
cargo recruitment (Dikic and Elazar, 2018).
TORC1 controls autophagy by directly impinging on the yeast
Atg1 and mammalian ULK1 kinase complexes. In yeast, TORC1
inhibits Atg1 kinase activity and, consequently, autophagy by
directly phosphorylating the Atg1 kinase complex subunit
Atg13 (Kamada et al., 2000, 2010). In mammals, mTORC1 phos-
phorylates both ATG13 and ULK1 (Hosokawa et al., 2009; Jung
et al., 2009; Kim et al., 2011). Current knowledge suggests a sim-
ple linear relationship between TORC1 and Atg1. However, reg-
ulatory modules that critically deﬁne cellular ﬁtness are often
embedded into multilayered mechanisms that ensure robust
cellular responses. Accordingly, robustness can be generated
by redundancies and inbuilt cross-communication between ele-
ments of signaling pathways, which ensure that only stimuli of
the appropriate strength and duration are able to turn on or off
their respective cellular responses (Azeloglu and Iyengar,
2015). Whether TORC1 and Atg1 are more intricately intercon-
nected through such mechanisms is largely unanswered. In
part, this is because the compendium of TORC1 and Atg1 target
residues is currently incomplete. To address this outstanding
issue, we decided to develop a mass spectrometry (MS)-based
phosphoproteomics strategy that combines global proteomics
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screens in vivo with targeted in vitro protein kinase assays. Spe-
ciﬁcally, we present here the currently largest set of TORC1-
dependent phosphorylation events in the yeast Saccharomyces
cerevisiae; identify numerous hitherto unknown TORC1 and Atg1
effectors; and characterize functionally relevant, new TORC1
target sites on Atg1 complex subunits. Our combined data high-
light the existence of a sophisticated network of bi-directional
regulatory feedback loops and nodes of convergence between
TORC1 and Atg1, indicating that these signaling hubs are
much more intricately interconnected than previously realized.
RESULTS
The Rapamycin-Sensitive Phosphoproteome:
Modulation of Pathways Controlling Protein
Homeostasis
To cover comprehensively the potential TORC1 and Atg1 target
sites, we performed a set of 10 stable isotope labeling by amino
Figure 1. Quantitative Phosphoproteomics
Analyses of Rapamycin-Treated Yeast Cells
(A) Quantitative MS-based proteomics workﬂow.
Yeast cells were labeled by Lys0, Arg0 (light), Lys4,
Arg6 (medium), or Lys8 Arg10 (heavy) amino acid
variants.
(B) Identiﬁed and quantiﬁed phosphosites of all 10
SILAC experiments. Data-ﬁltering steps are indi-
cated.
(C) Pie chart of identiﬁed pSer, pThr, and pTyr
sites.
(D) Cumulatively identiﬁed phosphosites in 10
SILAC experiments indicate the saturation of
identiﬁable phosphorylation sites. Identiﬁed site
numbers (gray squares) were ﬁtted with the least
square optimization predicting a maximum num-
ber of identiﬁcations of 45,109 sites (black line).
See also Figure S1.
acids in cell culture (SILAC)-based quanti-
tative phosphoproteomics experiments
comparing wild-type (WT) and atg1D cells
in the presence and absence of the highly
speciﬁc allosteric TORC1 inhibitor rapa-
mycin (Bentley and Banker, 2015; Har-
ding et al., 1989; Heitman et al., 1991;
Yang et al., 2013). Differentially labeled
cells were treated, or untreated, for
30 min with rapamycin before mixing pel-
lets and processing phosphopeptides for
MS/MS analysis (Batth et al., 2014) (Fig-
ure 1A; see STAR Methods for details).
The 10 SILAC experiments recorded ﬁve
biological replicates, each comparing
the responses of WT and atg1D cells to
rapamycin treatment (Figures S1A and
S1B). In total, we identiﬁed more than
36,600 phosphosites on 3,508 proteins
(Figure 1B)—on average, more than
20,000 sites per experiment. Of these
modiﬁcations, 76% were on serines, 23% on threonines, and
1% on tyrosines, which is congruent with published data (Batth
et al., 2018; Paulo and Gygi, 2015) (Figure 1C). The number of
newly identiﬁed sites per replicate indicated that we approached
saturation, and we estimate that our experimental setup would
allow us to identify a maximum of about 45,000 phosphorylation
sites (Figure 1D; see STAR Methods for details). Thus, our data-
set appears to cover more than 80% of the detectable yeast
phosphoproteome.
Of the 36,600 identiﬁed sites, more than 32,000were quantiﬁed
(Figure 1B). To identify robust phosphorylation-based responses
to rapamycin treatment, we stringently ﬁltered the generated
data: sites had to be localized to a speciﬁc amino acid residue
with a probability >0.75 (class I sites according to Olsen et al.
[2006]); had to be quantiﬁed in a minimum of three biological rep-
licates; and were normalized to respective protein abundances to
separate regulated phosphosites from regulated proteins. A total
of 23,375phosphosites fulﬁlled thesecriteria (Figure1B;TableS1).
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To identify sites that exhibited a signiﬁcant fold change in
phosphorylation due to rapamycin treatment, we generated a
statistical model combining all the biological replicates and sites
into a single analysis. The SILAC experiments were split into two
groups to identify (1) potential TORC1-regulated sites that re-
sponded negatively to rapamycin treatment and (2) potential
Atg1-regulated sites that responded positively to rapamycin
treatment. TORC1 sites had to be signiﬁcantly downregulated
inWT cells plus rapamycin compared toWT cells minus rapamy-
cin (I in Figure 3), atg1D cells plus rapamycin compared to atg1D
cells minus rapamycin (II in Figure 3), and WT cells plus rapamy-
cin compared to atg1D cells minus rapamycin (III in Figure 3).
Atg1 sites had to be signiﬁcantly upregulated in (I), (III), and (IV)
WT cells plus rapamycin compared to atg1D cells plus rapamy-
cin. In addition, Atg1 sites should exhibit no change or a signiﬁ-
cantly smaller change in experiment (2) compared to (1). As ﬁve
biological replicates per condition were performed, 15 replicates
per protein kinase were used to identify signiﬁcantly regulated
sites. Speciﬁcally, we used a random effect model considering
the variability among biological replicates, among sites, as well
as the number of replicates for each site. Next, the average
fold changes and their corresponding 95% conﬁdence intervals
were extracted for each site (Figure 2A). This led to a ﬁnal list of
586 sites (on 309 proteins) and 162 sites (on 128 proteins) that
were signiﬁcantly down- and upregulated by rapamycin treat-
ment, respectively (min. average fold change of 2; p < 0.05; Table
S1). This list included less than 2.5% of the quantiﬁed phospho-
sites, which reﬂects the stringent criteria used for deﬁning robust
phosphorylation-based signaling responses to rapamycin treat-
ment. Notably, our data cover on average 76% (67%–85%; Fig-
ure S1C) of all quantiﬁed phosphosites in similar phosphopro-
teomics datasets (Iesmantavicius et al., 2014; Oliveira et al.,
2015; Paulo and Gygi, 2015; Soulard et al., 2010) and list
14,599 additional, hitherto unknown phosphorylation events.
Our study further corroborates, on average, 12% of the reported
rapamycin-sensitive sites (4%–15%; Figure S1D). Importantly,
our study overlaps to a larger extent with published datasets
than the respective datasets with one another when considering
the total number of rapamycin-sensitive sites.
Virtually all of the previously known proximal TORC1 targets
were identiﬁed as rapamycin-sensitive, including Atg13 (Ka-
mada et al., 2010), Lst4 (Pe´li-Gulli et al., 2017), Sch9 (Urban
et al., 2007), Sfp1 (Lempia¨inen et al., 2009), Ypk3 (Gonza´lez
et al., 2015; Yerlikaya et al., 2016), and Vps27 (Hatakeyama
et al., 2019) (Table S2). In addition, we detected numerous po-
tential TORC1 target residues within the TORC1 subunit Tco89
(Reinke et al., 2004), which reveals that TORC1 undergoes
extensive autophosphorylation. Analyzing the amino acid se-
quences ﬂanking the regulated phosphosites of potential
TORC1 targets, we found similarities to the published yeast
and human consensus phosphorylation motifs with proline,
aliphatic, or aromatic residues in position +1 (Kang et al., 2013;
Mok et al., 2010; Oliveira et al., 2015; Urban et al., 2007) (Fig-
ure 2B). The two arginine residues in positions 3 and 2
perfectly match with a consensus phosphorylation site assigned
to the direct TORC1 target and protein kinase Sch9 (Huber et al.,
2009), indicating that our dataset probably contains Sch9 sub-
strates (see below).
Among the proteins that are phosphorylated in an Atg1-
dependent manner in rapamycin-treated cells, our analyses
gratifyingly distinguished the known Atg1 target proteins Atg2,
Atg9, and Atg29 (Mao et al., 2013; Papinski et al., 2014). More-
over, the Atg1 consensus motif analysis infers aliphatic amino
acid residues in position 3 (Figure 2B), which matches well
with the previously proposed Atg1/ULK1 motifs (Egan et al.,
2015; Papinski et al., 2014). Thus, our data appear to be of
high quality, as they largely conﬁrm current knowledge.
To get a global overview of TORC1- and Atg1-regulated
signaling pathways and cellular processes, we next performed
Gene Ontology (GO) term enrichment analyses of proteins car-
rying regulated phosphosites. Potential TORC1 targets were
signiﬁcantly enriched in proteins involved in metabolic pro-
cesses and positive regulation of gene expression (p < 0.05,
Bonferroni corrected; Figure 2C; Table S3). Potential Atg1 tar-
gets were signiﬁcantly enriched in proteins involved in retrograde
transport and autophagy (Figure 2C; Table S3). Besides corrob-
orating the known cellular functions, our data indicate that both
kinase complexes control additional processes that are impor-
tant for protein homeostasis (e.g., transcription and vacuole
organization). Interestingly, we also identiﬁed a signiﬁcant
enrichment of regulated sites on protein kinases, indicating
that rapamycin treatment modulates the activities of protein ki-
nases other than solely TORC1 and Atg1, which is also sug-
gested by our motif analysis (see above; Figures 2B and 2C).
To pinpoint new TORC1 effector and/or target kinases, we iso-
lated enriched linear phosphorylation motifs from the rapamy-
cin-sensitive phosphorylation sites and used KinomeXplorer to
identify kinases capable of phosphorylating them (Figure 2D)
(Horn et al., 2014). We identiﬁed four and ﬁve motifs within the
down- and upregulated sites, respectively. Expectedly, rapamy-
cin appeared to have negative effects on Sch9 and the protein
kinase A isoforms Tpk1 and Tpk2 (Soulard et al., 2010; Urban
et al., 2007). Also, the known TORC1 downstream effector
Gcn2 was identiﬁed in these analyses (Cherkasova and Hinne-
busch, 2003). Interestingly, next to Atg1, the DNA-damage-
responsive, phosphatidylinositol-kinase-related kinases Mec1
and Tel1 appeared to be capable of phosphorylating sites upre-
gulated by rapamycin treatment (Figure 2D). Mec1 has recently
been shown to be critical for both the induction of autophagy af-
ter genotoxic treatment and for glucose starvation-induced
autophagy (Eapen et al., 2017; Yi et al., 2017). Our data therefore
suggest that Mec1 and Tel1 may be able to act in concert with or
take over Atg1 functions under speciﬁc conditions (Corcoles-
Saez et al., 2018). The extensive effects of rapamycin treatment
on the kinome inspired us to perform a more detailed analysis of
protein kinases carrying regulated phosphosites that may be
functionally relevant.
TORC1 and Atg1 Regulate Cell Homeostasis through a
Highly Cross-Connected Network of Protein Kinases
In total, we identiﬁed 23 protein and 3 lipid kinases harboring
deﬁned phosphoresidues that are signiﬁcantly regulated by
either TORC1 or Atg1 (Figure 3). Of the ones regulated by
TORC1, Sch9 and Ypk3 are bona ﬁde proximal targets (Gonza´lez
et al., 2015;Martin et al., 2004; Urban et al., 2007; Yerlikaya et al.,
2016), while Npr1 and Gcn2 have been described as distally
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controlled by TORC1 (Garcia-Barrio et al., 2002; Schmidt et al.,
1998). In addition, several of the other TORC1-controlled protein
kinases have previously been found to be part of the TORC1-
associated protein kinase network (Breitkreutz et al., 2010),
including Bck1, Ksp1, and Sky1, which were also linked to auto-
phagic processes (Krause and Gray, 2002; Manjithaya et al.,
2010; Rodrı´guez-Lombardero et al., 2014; Umekawa and Klion-
sky, 2012). Besides precisely pinpointing the phosphorylation
events that are likely functionally relevant for processing signals
that emanate from TORC1, these ﬁndings uncover the existence
of multiple regulatory layers by which TORC1 may control auto-
phagic processes other than phosphorylating Atg13 (Kamada
et al., 2000). Of note, we also identiﬁed four potential TORC1
sites on Atg1, in agreement with data obtained on mammalian
ULK1 (Hosokawa et al., 2009; Jung et al., 2009; Kim et al., 2011).
Analysis of the Atg1-dependent phosphoproteome revealed a
similarly complex network of interactions speciﬁcally with the
TORC1 signaling branch. For instance, Atg1may feedback regu-
late TORC1 by (directly or indirectly) (1) impinging on Seh1 and
Sea4, two subunits of the SEACAT complex that controls
TORC1 through the Rag GTPases (Panchaud et al., 2013); (2)
regulating Ser327 phosphorylation within the TORC1 subunit
Figure 2. The Rapamycin-Sensitive Phosphoproteome
(A) Statistical approach for the identiﬁcation of signiﬁcant regulated phosphosites by rapamycin treatment. The gray curve indicates the SILAC ratio distribution of
23,375 phosphosites, comparing cells grown in the presence and absence of rapamycin (30 min). As an example for regulated and non-regulated sites, 12 sites
are shown with their average values and conﬁdence intervals. Blue sites are signiﬁcantly downregulated, and red sites are signiﬁcantly upregulated by rapamycin
treatment (p > 0.05). Two-fold cutoff values are marked by colored dashed lines.
(B)Motif analyses of potential TORC1 and Atg1 phosphosites respondingminimally 2-fold to rapamycin treatment. Potential TORC1 sites are downregulated, and
potential Atg1 sites are upregulated by rapamycin treatment.
(C) GO term enrichment analysis of proteins carrying positive and negative regulated phosphosites highlights perturbed cell homeostasis.
(D) Motif analyses and predictions of kinases potentially being perturbed by rapamycin treatment.
See also Figure S1.
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Tco89; and/or (3) controlling the Ser445/Ser449 phosphorylation
within the PI3-kinase Vps34 that is key for TORC1 and auto-
phagy activation (Reidick et al., 2017; Tanigawa and Maeda,
2017) (Figure 3). Lastly, Atg1 also converges with TORC1 on
Gcn2. Thus, Atg1 signaling seems to be much more intimately
connected to TORC1 signaling than previously anticipated. Not
surprisingly, this close relationship also extends to include the
Snf1/AMPK complex, a major energy sensor and negative regu-
lator of TORC1 in eukaryotic cells (Figure 3) (Hughes Hallett et al.,
2015). Accordingly, TORC1may feedback regulate Snf1 by con-
trolling the phosphorylation state of various residues in the
Snf1-activating protein kinase Sak1 and the Snf1 complex
b-subunits Sip1 and Gal83 (Elbing et al., 2006; Schmidt and
McCartney, 2000).
TORC1 andAtg1 Regulate Autophagy onMultiple Layers
Our SILAC-based screen indicated that Atg2, Atg9, Atg13,
Atg26, and Atg29 carried both potential TORC1 and Atg1 target
residues (Figure 4A). Using a phospho-speciﬁc antibody that
recognizes pSer554 on Atg13, we corroborated in one case
that a potential TORC1 target residue is indeed rapidly dephos-
phorylated in rapamycin-treated cells (Figure 4B). To test if any of
the identiﬁed phosphorylation events were bona ﬁde TORC1 or
Atg1 sites, we then puriﬁed the 36 Atg proteins of yeast that
are known to be involved in canonical autophagy (Wen and
Klionsky, 2016) and performed TORC1 and Atg1 in vitro kinase
assays coupled to quantitative MS as readout (Figure 4C) (Hata-
keyama et al., 2019; Pe´li-Gulli et al., 2017). Proteins were puriﬁed
from tandem afﬁnity puriﬁcation (TAP)- and glutathione S-trans-
ferase (GST)-tagged yeast collections (Gelperin et al., 2005; Zhu
et al., 2000) and kinase assays in combination with MS sample
processing were performed on molecular-weight cutoff ﬁlters
using 18O4-labeled ATP to separate in vitro from remnant in vivo
phosphorylation events (Figure 4D) (Xue et al., 2014; Zhou et al.,
2007). To identify direct phosphorylation events of Atg1 and
TORC1, we performed label-free quantitative proteomics exper-
iments comparing kinase assays with Atg1WT to the ones with
Atg1kinase dead, and kinase assays with TORC1 with or without
wortmannin (n = 3; Table S4), a PI3K inhibitor that potently in-
hibits TORC1 (Brunn et al., 1996; Urban et al., 2007). Of note,
background phosphorylation levels were similar for all Atg sub-
strates, and we did not identify elevated phosphorylation levels
of Atg1 complex members. The respective data covered 139
out of 182 phosphosites on both Atg proteins and TORC1 sub-
units that are reported in the SaccharomycesGenome Database
(76%; https://www.yeastgenome.org/). Notably, we further
identiﬁed 406 hitherto unknown sites, indicating that our dataset
includes and signiﬁcantly expands the known, potentially biolog-
ically relevant target sites of Atg1 and TORC1 on Atg proteins.
In vitro analyses conﬁrmed the Atg1motif generated using in vivo
data (Figure 4E). The inferred in vivo and in vitro TORC1 motifs,
however, differed substantially, which indicates that many of
the rapamycin-sensitive phosphosites might be regulated indi-
rectly by TORC1 effector kinases, such as Sch9 (Figure 2D), or
protein phosphatases, such as Ptc2/3, that remove inhibitory
TORC1 phosphosites from the Atg1-Atg13 complex (Memisoglu
et al., 2019). From the in vitro data, we conclude that TORC1
phosphorylates preferentially serine residues that are followed
Figure 3. Kinases Carrying Rapamycin-Sensitive Phosphosites
Proteins carrying signiﬁcantly regulated phosphosites were screened for ki-
nases and known members of TORC1 and Atg1 signaling pathways. Potential
TORC1 sites have a negative log2 SILAC ratio and are colored blue, and po-
tential Atg1 sites have a positive log2 SILAC ratio and are colored red. If sites
were not detected in speciﬁc experiments, their boxes are colored gray. Sites
may be either activating or inhibiting. It is assumed that TORC1 and Atg1 have
opposing effects on targets (i.e., act either activating or inhibiting). Solid lines
indicate known interactions, and dashed lines indicate potential interactions
identiﬁed in this study. Note: except Sky1 (n = 3), all kinases were quantiﬁed in
a minimum of four replicates.
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Figure 4. Filter-Aided In Vitro Kinase Assay to Identify Direct TORC1 and Atg1 Substrates
(A) Atg protein network carrying potential in vivo Atg1 and TORC1 sites generated by STRING database (DB). The thickness of connections indicates the strength
of data support.
(B) Immunoblot analysis highlighting that Atg13 is phosphorylated by TORC1 on S554. A custom-made, site-speciﬁc antibody recognizing the phosphorylation of
S554 on Atg13 and an anti-hemagglutinin (HA) antibody were used.
(legend continued on next page)
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by hydrophobic residues in position +1. In vitro kinase assays
appear, therefore, to be a valuable tool to corroborate direct
TORC1 targets within the Atg protein network (Kang et al., 2013).
We identiﬁed phosphosites on 20 of the 36 puriﬁed Atg pro-
teins, several of them being conserved in higher organisms (Fig-
ures S2 and S3; Table S4). By combining in vivo and in vitro
analyses, it became evident that Atg1 and TORC1 likely regu-
late autophagy on multiple layers. So far, it was thought that
TORC1 regulates solely the initiation of autophagy by phos-
phorylating Atg13. Our data, however, reveal additional
TORC1 sites on Atg1, Atg2, Atg9, and Atg29 (Figures 4F and
S2). Whereas Atg29 is also part of the Atg1 complex regulating
the signal initiation, Atg2 and Atg9 take part in downstream pro-
cesses that are critical for phagophore nucleation and expan-
sion (Wen and Klionsky, 2016). The role of Atg1 appeared
even more intertwined with the rest of the Atg machinery. It
phosphorylated Atg2, Atg9, Atg12, Atg13, Atg23, and Atg29
(Figures 4F and S2), having potential implications in multiple
steps of autophagosome biogenesis (Wen and Klionsky,
2016). Thus, TORC1 and Atg1 signaling appeared closely inter-
connected, phosphorylating multiple members of the Atg pro-
tein network, which may allow robust and coordinated control
of autophagy initiation.
To test for biological relevance of the newly identiﬁed phos-
phosites, we analyzed their effects on autophagy using the
Pho8D60 assay as described (Noda et al., 1995). We focused
on the Atg1 complex member Atg29 and generated an atg29D
strain, which displayed a signiﬁcant block in autophagy activity
under nitrogen starvation conditions (Figures 4G and 4H). In
agreement with published data, serine-to-alanine mutations of
Atg1 target sites Ser197, Ser199, and Ser201 (3SA) signiﬁcantly
reduced autophagy (Figures 4G and S3A; p < 0.01) (Mao et al.,
2013). Importantly, a single phospho-mimicking threonine-to-
glutamate mutation of the newly identiﬁed TORC1 target site
Thr115 (T115E) also signiﬁcantly decreased autophagic activity
under starvation conditions, whereas a threonine-to-alanine mu-
tation (T115A) had no effect (Figure 4G; p < 0.001). Thus, Atg29
integrates both Atg1 and TORC1 signaling in vivo to properly
regulate autophagy.
DISCUSSION
In this study, we comprehensively characterized signaling events
regulated by two conserved kinase complexes—the TORC1 and
its downstream effector Atg1—critical for cell homeostasis dur-
ing nutrient deprivation. Moreover, we identiﬁed a multilayered
control of autophagy by TORC1 and Atg1 signaling, including
negative and positive feedback loops, by generating the
currently most comprehensive dataset of rapamycin-sensitive,
phosphorylation-based signaling events in the budding yeast
S. cerevisiae, covering 36,600 phosphorylation sites and over
80% of the technically detectable phosphorylated residues.
Compared to published reports, our data corroborate, on
average, 12% of the reported rapamycin-sensitive sites, which
highlights the experimental and biological noise of phosphopro-
teomics studies. To address this challenge, we decided to
perform ﬁve biological replicates and to stringently ﬁlter the re-
ported regulated sites using a random effect model.
The question if speciﬁc sites are direct kinase targets or if the
observed effects are of secondary nature conveyed by down-
stream effector kinases is not easy to address. The kinetic anal-
ysis of in vivo events may shed light onto primary and secondary
events (Oliveira et al., 2015; Rigbolt et al., 2014). However, the
gold standard for proving direct kinase-substrate interactions
is still classical in vitro kinase assays. Therefore, we puriﬁed
36 yeast Atg proteins that are involved in starvation-induced
autophagy and used them as substrates in in vitro protein kinase
assays (Wen and Klionsky, 2016). Notably, we ﬁltered the in vitro
data with in vivo recordings to eliminate non-physiological phos-
phorylation events in vitro (e.g., due to missing binding partners
or cellular compartmentalization). Thus, the sites shortlisted are
likely to correspond to bona ﬁde TORC1 or Atg1 sites.
Within the set of protein kinases exhibiting potential TORC1
sites, we identiﬁed several that have previously been linked to
autophagic processes: (1) Bck1 mediates signals from Pkc1 to
Mkk1/2 within the cell wall integrity MAPK signaling pathway
(Krause and Gray, 2002), which is required for the induction of
pexophagy in yeast (Manjithaya et al., 2010); (2) Ksp1 inhibits
autophagy by antagonizing the dephosphorylation of Atg13
(Umekawa and Klionsky, 2012); and (3) Sky1 modulates mitoph-
agy (Rodrı´guez-Lombardero et al., 2014). Shared signaling
events between organelle-speciﬁc autophagy subtypes and
bulk autophagy might indicate that selective autophagy contrib-
utes to the bulk protein turnover observed in nutrient-starvation
conditions. Supporting this hypothesis, we identiﬁed regulated
phosphosites on Cue5, a ubiquitin-Atg8 receptor involved in
the selective degradation of polyQ proteins (Lu et al., 2014), on
the ubiquitin protease Ubp3/Bre5 as being critical for ribophagy
(C) Sequence mapping of proteins used in in vitro kinase assays. Sequence coverage of Atg proteins puriﬁed from GST- and TAP-tagged yeast strains is shown.
Trypsin was used as protease for bottom-up proteomics experiments. Error bars indicate standard deviations (n = 3).
(D) Workﬂow of the ﬁlter-aided in vitro kinase assay. Phosphopeptides enriched by TiO2 chromatography are analyzed by LC-MS/MS.
(E) Sequence motifs of phosphosites enriched in TORC1 and Atg1 in vitro kinase assays.
(F) Graphic representation of puriﬁed Atg29 used in in vitro kinase assays. In vitro TORC1 sites are annotated in blue and Atg1 sites in red. Sites that are underlined
and marked in bold were identiﬁed by in vivo and in vitro assays. Protein sequences covered by MS analyses are marked in green.
(G) Cells (pho8D60 labeled withWT; pho8D60 atg29D labeled with atg29D) were transformed with an empty vector (empty) or vectors encoding the indicated HA-
tagged Atg29 variants. Cells were grown exponentially for 24 h in SD (+N) and then shifted to SD-N for 3 h (–N). Protein extracts were analyzed by ALP assay. Error
bars were obtained from at least three independent repeats and indicate SDs. Pho8D60 phosphatase activities were normalized to the ones of nitrogen-starved
WT cells (100%). **p < 0.01; ***p < 0.001, t test.
(H) In parallel, protein extracts were also subjected to immunoblot analysis (using anti-HA antibodies) to assess the appropriate expression of the HA-tagged
Atg29 variants (upper part of the panel). Ponceau staining served as loading controls (lower part). Note that the altered migration pattern of Atg29-T115E is likely
caused by an altered charge state of the protein due to the introduction of an acidic amino acid.
See also Figures S2 and S3.
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(Kraft et al., 2008) and on Nvj1 and Vac8, which cooperate in
piecemeal microautophagy of the nucleus (Roberts et al.,
2003) (Table S1). Importantly, we characterized Atg1, Atg2,
Atg9, and Atg29 as potential new direct TORC1 targets within
the Atg machinery. Thus, similar to the situation in mammalian
cells where ULK1 itself was identiﬁed as an mTORC1 target (Ho-
sokawa et al., 2009; Jung et al., 2009), we identiﬁed one phos-
phosite (Ser518) on Atg1 as a potential direct TORC1 site. Inter-
estingly, of the three additional sites that were identiﬁed as
negatively regulated by rapamycin treatment in vivo, only
Ser677 and Ser680 lie within the EAT/tMIT domain, which is crit-
ical for Atg13 binding (Fujioka et al., 2014; Ragusa et al., 2012).
Thus, TORC1 may directly inﬂuence Atg1-Atg13 activity by
phosphorylating both complex members. In addition, TORC1
seems to also negatively regulate the second subcomplex of
the Atg1 holo-complex, Atg17-Atg31-Atg29, by phosphorylating
Thr115 of Atg29.
Next to TORC1 target sites, we also characterized 162 poten-
tial Atg1 sites on 128 proteins. Our data conﬁrmed phosphoryla-
tions on Atg2 (Ser249) and Atg9 (Ser802 and Ser969) (Papinski
et al., 2014), but the majority of the identiﬁed sites are so far un-
known and need future investigations to understand their signif-
icance in autophagy and beyond.Within the Atg protein network,
we identiﬁed new bona ﬁde Atg1 sites on Atg2, Atg9, Atg13,
Atg23, Atg29, and Atg33, an outer mitochondrial membrane pro-
tein involved in mitophagy (Kanki et al., 2009). It appears that
Atg1 is not only critical for autophagy initiation, but it also con-
trols the entire pathway, including organelle-speciﬁc autophagy
subtypes as well as autophagosome-vacuole fusion, by phos-
phorylating the SNARE proteins Vti1 and Ykt6 (Table S1) (Bas
et al., 2018; Gao et al., 2018). Importantly, Atg1 seems to not
only receive input from TORC1, but also regulate TORC1 activity
by phosphorylating members of the SEACAT complex, an acti-
vator of TORC1, which inhibits SEACIT, a GTPase-activating
protein (GAP) of Gtr1. Whether Atg1 phosphorylation of SEACAT
acts positively or negatively on TORC1 activity will have to be ad-
dressed in future studies. Nevertheless, the functions of Atg1
seem to be broader than anticipated, potentially controlling cell
homeostasis by phosphorylating target proteins outside of the
canonical Atg protein network. In summary, our study uncovers
a multilayered signaling network, which serves to coordinate
TORC1 and Atg1 activities to robustly tune autophagy in
response to nutritional cues, and it lays the groundwork for future
mechanistic approaches.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
anti-Atg13-pSer554 De Virgilio Lab N/A
anti-HA Sigma-Aldrich 11583816001; RRID:AB_514505
Bacterial and Virus Strains
E. coli Rosetta (DE3) Novagen 70954
E. coli DH5a CGSC 12384
Chemicals, Peptides, and Recombinant Proteins
Protease Complete Inhibitor
Cocktail Tablets
Roche 11-697-498-001
GSH Beads GE Healthcare 1707-5605
Ni-NTA Beads QIAGEN 30210
Arg10 Sigma-Aldrich 608033
Arg6 Sigma-Aldrich 643440
Lys4 Sigma-Aldrich 616192
Lys8 Sigma-Aldrich 608041
PhosSTOP Roche 04-906-837-001
Rapamycin LC Laboratories R-5000
TFA Sigma-Aldrich 302031-100ML
Titanium dioxide GL Sciences 5020-75010
Trypsin Promega V5113
Wortmannin LC Laboratories W-2990
g-[18O4]-ATP Cambridge Isotope Laboratories OLM-7858-20
10 kD MW cutoff ﬁlter PALL OD010C34
C8 disc 3M Empore 14-386
C18 disc 3M Empore 14-386-2
Lys-C FUJIFILM Wako Pure Chemical Corporation 129-02541
HR-X Column Macherey-Nagel 730936P45
C18 Cartridges Macherey-Nagel 731802
MS-grade Water VWR 23595.328
MS-grade Acetonitrile VWR 20060.320
C18 Column for High pH Fractionation Waters 186003034
Pierce Anti-HA Magnetic Beads Thermo Scientiﬁc 88837
Pefabloc Sigma-Aldrich 76307
Lambda Protein Phosphatase NEB P0753L
Protein MettaloPhosphatases Buffer NEB B0761
a-Naphthyl Phosphate Disodium Salt Sigma-Aldrich N7255
Critical Commercial Assays
Pierce BCA Protein Assay Kit Thermo Scientiﬁc 23227
ECL Western Blotting Detection GE Healthcare RPN2106
Deposited Data
MS-RAW ﬁles ProteomeXchange PXD013271
Experimental Models: Organisms/Strains
TB50a Schmelzle et al., 2004 MATa; trp1, his3, ura3-52, leu2-3,112, rme1
RL170-2C (Figures S2 and S3) Hatakeyama et al., 2019 [TB50a] TCO89-TAP::TRP1
BY4741 (Figures S2 and S3) Euroscarf MATa; his3D1, leu2D0, met15D0, ura3D0
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Y14547 (Figures S2 and S3) Euroscarf [BY4741] atg1D::kanMX4
MP5102 (Figures S2 and S3) Euroscarf [BY4741] atg13D::kanMX4
Y258 (Figures S2 and S3) Zhu et al., 2001 MATa; his4-580, leu2-3,112, ura3-52, pep4-3
SR5190 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG2-TAP
SR5192 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG3-TAP
SR5194 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG5-TAP
SR5195 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG6-TAP
SR5193(Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG4
SR5196 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG7
SR5197 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG8
SR5198 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG9
SR5199 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG10
SR5200 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG11-TAP
SR5201 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG12
SR5202 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG13
SR5203 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG14
SR5204 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG15-TAP
SR5205 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG16
SR5206 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG17
SR5207 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG18-TAP
SR5208 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG19-TAP
SR5209 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG20-TAP
SR5210 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG21-TAP
SR5211 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG22-TAP
SR5212 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG23
SR5213 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-SNX4
SR5214 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG26-TAP
SR5215 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG27-TAP
SR5216 (Figures 4F, S2, and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG29
SR5217 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG31-TAP
SR5218 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG32
SR5219 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG33-TAP
SR5220 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG34-TAP
SR5221 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG36-TAP
SR5222 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG38-TAP
SR5223 (Figures S2 and S3) Open Biosystems [Y258] pBG1805-GAL1-ATG39-TAP
SR5224 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG40
SR5225 (Figures S2 and S3) Open Biosystems [Y258] pEGH-GAL1-GST-ATG41
TS139 (Figures 4G and 4H) Schmelzle et al., 2004 [TB50a] pho8D60
SR4934 (Figures 4G and 4H) This study [TB50a] pho8D60, atg29D::kanMX
SR4991 (Figures S2 and S3) This study [BY4741] arg4D::URA3, lys2D, ATG29-3HA-kanMX
MJ5682 (Figures S2 and S3) This study [BY4741] arg4D::His3-MX6, lys2D::HphMX
MJ5691 (Figures S2 and S3) This study [BY4741] arg4D::His3-MX6, lys2D::HphMX,
atg1D::kanMX
Recombinant DNA
p1613 (Figures S2 and S3) Kawamata et al., 2008 [pRS316] HA-ATG1
p1614 (Figures S2 and S3) Kawamata et al., 2008 [pRS316] HA-atg1D211A
p3577 (Figure 4B) Yamamoto et al., 2016 [pR316] ATG13-2HA
(Continued on next page)
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents, i.e., plasmids, yeast strains and antibodies generated in this study,
should be directed to and will be fulﬁlled by the Lead Contact, Jo¨rn Dengjel (joern.dengjel@unifr.ch). This study did not generate
new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Yeast strains, plasmids, and growth conditions
Saccharomyces cerevisiae strains and plasmids are listed in Table S5. Unless otherwise stated, yeast strains were grown to mid log
phase in SDmedium (0.17% yeast nitrogen base, 0.5% ammonium sulfate and 2% glucose). SD medium lacking ammonium sulfate
and amino acids was used to starve cells. For Atg protein puriﬁcations, we grew cells in medium containing 2% rafﬁnose to OD600 of
0.5. Galactose was then added to a ﬁnal concentration of 2% to induce the expression of proteins during 6 h, followed by rapamycin
treatment (200 ng/mL) for 30 min. Cells were collected, lysed in buffer containing 100 mM TRIS pH7.5, 300 mM NaCl, 1% NP40 and
1x proteases inhibitors (Roche), and either puriﬁed with GSH or Ni-NTA beads (GE) as in Zhu et al. (2000).
Sample preparation of in vivo SILAC experiments
The yeast strains were grown in synthetic dextrose complete medium containing either non-labeled or labeled lysine and arginine
variants: ‘‘Heavy’’ L-arginine-13C6-
15N4 (Arg10) and L-lysine-
13C6-
15N2 (Lys8), or ‘‘medium-heavy’’ L-arginine-
13C6 (Arg6) and L-lysi-
ne-2H4 (Lys4) amino acids (Sigma-Aldrich) were used as labels. In total, ten SILAC experiments were performed using the following
label scheme:
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
p3632 (Figure 4B) This study [pRS416] atg13S554A-3HA
p3425 (Figures 4G and 4H) This study [pRS416] ATG29-3HA
p3473 (Figures 4G and 4H) This study [pRS416] atg293SA-3HA
p3504 (Figures 4G and 4H) This study [pRS416] atg29T115A-3HA
p3541 (Figures 4G and 4H) This study [pRS416] atg29T115E-3HA
pRS413 Sikorski and Hieter, 1989 CEN, ARS, HIS3
pRS414 Sikorski and Hieter, 1989 CEN, ARS, TRP1
pRS415 Sikorski and Hieter, 1989 CEN, ARS, LEU2
pRS416 Sikorski and Hieter, 1989 CEN, ARS, URA3
Software and Algorithms
ImageJ NIH https://imagej.nih.gov/ij/index.html
Photoshop Adobe https://www.adobe.com/
MaxQuant Cox and Mann, 2008 https://maxquant.net/maxquant/
Perseus Tyanova et al., 2016 https://maxquant.net/perseus/
Cytoscape Shannon et al., 2003 https://cytoscape.org/
ClueGO Bindea et al., 2009 http://apps.cytoscape.org/apps/cluego
Motif Analysis NIH https://www.phosphosite.org/staticMotifAnalysis.
action
Sequence Logo NIH https://www.phosphosite.org/
sequenceLogoAction.action
Experiment/Label Light Medium-Heavy Heavy
ATG1_KO_1 KO-Rapa WT+Rapa KO+Rapa
ATG1_KO_2 KO+Rapa KO-Rapa WT+Rapa
ATG1_KO_3 WT+Rapa KO+Rapa KO-Rapa
ATG1_KO_4 KO-Rapa WT+Rapa KO+Rapa
ATG1_KO_5 KO+Rapa KO-Rapa WT+Rapa
WT_1 KO+Rapa WT+Rapa WT-Rapa
(Continued on next page)
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Cells were treated or not with 200 ng/mL rapamycin for 30 min. Dried TCA-treated cell pellets (50 mg) of each labeling were mixed.
Cells were broken by glass beads in urea buffer (8M urea, 50mMTris HCl (pH 8)). Debris was pelleted and the supernatant containing
cellular proteins was collected. These stepswere repeated 5 times to extract proteins. Proteins were reduced by 1mMDTT, alkylated
by 5 mM iodoacetamide and digested by Lys-C (Lysyl Endopeptidase, WAKO) for 4 h. The concentration of urea was diluted to 1 M
before overnight trypsin digestion (Promega).
On the second day, the samples were acidiﬁed using 50%TFA (ﬁnal concentration 0.5%) and centrifuged at 4000 rpm for 10min to
remove precipitations. Peptides were puriﬁed by SPE using HR-X columns in combination with C18 cartridges (Macherey-Nagel):
Buffer A, 0.1% formic acid in deionized water; Buffer B, 80% acetonitrile and 0.1% formic acid in deionized water. Elutes were frozen
in liquid nitrogen and lyophilized for overnight.
On the third day, peptides were fractionated by HpH reversed phase chromatography (Batth et al., 2014). The dry peptide powder
was suspended in 400 ml 5% ammonium hydroxide and fractionated using a Waters XBridge BEH130 C18 3.5 mm 4.6 3 250 mm
column on a Ultimate 3000 HPLC (Thermo Scientiﬁc). Peptides were injected with 0.1 ml/s. The ﬂowrate of the mobile phase was
1 ml/min. HpH buffer A contained 10 mM ammonium formate in deionized water and buffer B contained 10 mM ammonium formate
and 90%acetonitrile deionizedwater. Both buffers were adjusted to pH 10with ammonium hydroxide. Peptides were fractionated by
increasing acetonitrile concentration from 1% to 40%Buffer B in 25min. 96 fractions were collected in a 96 deepwell plate. Fractions
were mixed with an interval of 12 to yield 12 ﬁnal fractions. The peptides were acidiﬁed, frozen in liquid nitrogen and lyophilized for
overnight. On the fourth day, the dry peptides were suspended in 200 ml 80% acetonitrile with 1% TFA for further phosphopeptide
enrichment (see below).
METHOD DETAILS
Filter-Aided In Vitro Kinase Assay
For Atg1 assays, HA-tagged WT and kinase dead Atg1 were puriﬁed by immunoprecipitation using anti-HA magnetic beads
(Thermo Scientiﬁc). The beads were directly used for in vitro kinase assay. For TORC1 assays (Hatakeyama et al., 2019), to obtain
maximal TORC1 activity, 30 mg of puriﬁed TORC1 was incubated with 1 mM MnCl2 for 30 min. As a negative control, puriﬁed
TORC1 was inhibited with 6 mM wortmannin for 30 min. Atg proteins puriﬁed from yeast (Gelperin et al., 2005; Zhu et al.,
2000) and TORC1 or Atg1 variants were added onto 10 kD MW-cutoff ﬁlters (Pall) and incubated for 1 h at 30C in kinase buffer:
50 mM HEPES (pH 7.4), 150 mM NaCl, 0.625 mM DTT, PhosSTOP, 6.25 mM MgCl2, and 1.8 mM g-[
18O4]-ATP (Cambridge Isotope
Laboratory). The assay was stopped by the addition of 8 M urea and 1 mM DTT. Protein digestion for MS analysis was performed
overnight according to the FASP protocol (Wisniewski et al., 2009). On day 2, peptides were eluted twice with 100 mL 50 mM
ammonium bicarbonate into fresh tubes. Eluates were acidiﬁed with TFA to a ﬁnal concentration of 1% prior phosphopeptide
enrichment.
Phosphopeptide Enrichment
For both in vitro and in vivo experiments, phosphopeptides were enriched by TiO2 beads (GL Sciences), which were incubated with
300 mg/mL lactic acid in 80% acetonitrile, 1% TFA prior experiments (Zarei et al., 2016). Samples were incubated with a 2 mg TiO2
slurry for 30min at room temperature. For peptide elution, TiO2 beads were transferred to 200 mL pipette tips, which were blocked by
C8 discs (3M Empore). Tips were sequentially washed with 10% acetonitrile/1% TFA, 80% acetonitrile/1% TFA, and LC-MS grade
water. Phosphopeptides were eluted with 50 mL of 5% ammonia in 20% acetonitrile and 50 mL of 5% ammonia in 80% acetonitrile.
Eluates of single fractions were mixed and acidiﬁed with 20 mL of 10% formic acid. Samples were concentrated by vacuum concen-
tration and resuspended in 20 mL of 0.1% formic acid for LC-MS/MS analysis. The tip ﬂow-through was stored at 80C for non-
phosphopeptide analysis.
LC-MS/MS Analyses
LC-MS/MS measurements were performed on a QExactive (QE) Plus and HF-X mass spectrometer coupled to an EasyLC 1000 and
EasyLC 1200 nanoﬂow-HPLC, respectively (all Thermo Scientiﬁc). Peptides were fractionated on a fused silica HPLC-column tip (I.D.
75 mm, New Objective, self-packed with ReproSil-Pur 120 C18-AQ, 1.9 mm (Dr. Maisch) to a length of 20 cm) using a gradient of
Continued
Experiment/Label Light Medium-Heavy Heavy
WT_2 WT-Rapa WT+Rapa
WT_3 WT+Rapa WT-Rapa
WT_4 WT-Rapa WT+Rapa
WT_5 WT+Rapa WT-Rapa
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A (0.1% formic acid in water) and B (0.1% formic acid in 80% acetonitrile in water): samples were loaded with 0%Bwith a ﬂow rate of
600 nL/min; peptides were separated by 5%–30%Bwithin 85min with a ﬂow rate of 250 nL/min. Spray voltage was set to 2.3 kV and
the ion-transfer tube temperature to 250C; no sheath and auxiliary gas were used. Mass spectrometers were operated in the data-
dependent mode; after each MS scan (mass range m/z = 370 – 1750; resolution: 70’000 for QE Plus and 120’000 for HF-X) a
maximum of ten, or twelve MS/MS scans were performed using a normalized collision energy of 25%, a target value of 1’000 (QE
Plus)/50000 (HF-X) and a resolution of 17’500 for QE Plus and 30’000 for HF-X. MS raw ﬁles were analyzed using MaxQuant (version
1.6.2.10) (Cox and Mann, 2008) using a Uniprot full-length S. cerevisiae database (March, 2016) and common contaminants such as
keratins and enzymes used for in-gel digestion as reference. Carbamidomethylcysteine was set as ﬁxed modiﬁcation and protein
amino-terminal acetylation, serine-, threonine- and tyrosine- (heavy) phosphorylation, and oxidation of methionine were set as var-
iable modiﬁcations. The MS/MS tolerance was set to 20 ppm and three missed cleavages were allowed using trypsin/P as enzyme
speciﬁcity. Peptide, site, and protein FDR based on a forward-reverse database were set to 0.01, minimum peptide length was set to
7, the minimum score for modiﬁed peptides was 40, and minimum number of peptides for identiﬁcation of proteins was set to one,
which must be unique. The ‘‘match-between-run’’ option was used with a time window of 0.7 min. MaxQuant results were analyzed
using Perseus (Tyanova et al., 2016).
ALP assays for the determination of autophagic ﬂux and immunoblot analysis
Autophagy was induced by shifting the cells for 3 h to nitrogen starvation medium according to Noda et al. (1995). Autophagic ﬂux
was determined according to Klionsky et al. (2016). For immunoblot analyses, cell lysates were prepared as previously described
(Hatakeyama et al., 2019) and subjected to SDS-PAGE and immunoblotting experiments using the indicated antibodies. Anti-
Atg13-pSer554 antibodies were generated by GenScript. Yeast cells expressing plasmid-encoded Atg13-2HA were collected and
resuspended in lysis buffer (5 mM EDTA, 1% Triton X-100, protease inhibitor cocktail [Roche], Pefabloc [Sigma-AldrFich] and Phos-
STOP [Roche] in phosphate-buffered saline), and disruptedwith glass beads using a Precellys homogenizer. Atg13-2HAwas puriﬁed
by incubation with anti-HA magnetic beads (Pierce) and washed with lysis buffer. The beads were further washed with, and then re-
suspended in Protein MettalloPhosphatases buffer (NEB) supplemented with 1mMMnCl2 and incubated in the presence or absence
of Lambda protein phosphatase (NEB) for 30 min at 30C. The samples were incubated in Laemmli sample buffer for 10 min at 65C
and subjected to SDS-PAGE and immunoblot analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Wecombined themeasurement of the log2 fold change on each site and for the 15 replicates into a randomeffectmodel. Speciﬁcally,
we considered a priori the sites as a random effect andwe included the variability among replicates by also considering the replicates
as a random effect. The model reads as
yij = a+ si + rj + εij
where yij is the log2 fold change at the site i and for the replicate j. The variable si represents the log2fold change a site i, for which the
potential variability among the replicates, the term rj, has been taken into account. The model assumes a common intercept a and
residuals εij. The model has been ﬁtted to the data using the function lmer of the library lme4 (Bates et al., 2015) in the statistical soft-
ware R (R Team, 2019).
Then, a posterior, we extracted the average effect size in log2 fold change and its standard error effect size for each site. This is
done by the function ranef of the library lme4. From these posterior values, each site is assigned an average effect size and its cor-
responding 95% conﬁdence interval:
average effect size±qtð0:975;d:f : = number of replicates at a given siteÞ X standard error:
The value qt represents the 0.975 quantile of the Student distribution for a degree of freedom of d.f., so that the exact number of
replicates available for a given site is taken into account into the computation of the conﬁdence interval. If the conﬁdence interval
includes values of zeros, then there is no statistically signiﬁcant log2 fold change, whereas if the conﬁdence interval is above (below)
zeros, then there is statistical evidence for upregulation (downregulation) (see Figure 2A).
GO-term analyses were performed with Cytoscape 3.7.1 (Shannon et al., 2003) and ClueGO 2.5.3. (Bindea et al., 2009).
Ontology enrichment (background: genome) was calculated using those genes, whose proteins carried phosphosites that
were min. 2-fold regulated, either positive or negative. GO-biological process (BP), -cellular component (CC) and KEGG
were selected for calculations. GO term fusion was used. Only pathways with a p value % 0.05 were determined as signiﬁcant
(Bonferroni corrected). GO tree interval was set between 4 and 8. GO clusters contained at least 5 genes or 10% of all
input genes. Enrichment/depletion (two-sided hypergenometric test) and Bonferroni p value correction were selected for statis-
tical analyses. Sequence logos and motif analyses were performed using the service of the PhosphoSitePlus website. The
background for both calculations was based on the respective input sequences. Motifs with a p value % 0.001 and a support
threshold R 0.05 were selected. To identify the maximum number of identiﬁable phosphosites we ﬁtted the cumulative sum of
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newly identiﬁed phosphosites per experiment with a least square optimization using Excel. Homolog sequences alignments were
performed with Clustal Omega, a web tool of EMBL-EBI, using default settings (Madeira et al., 2019). Proteins homologs were
extracted from UniProt.
DATA AND CODE AVAILABILITY
Themass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository
with the dataset identiﬁer PRIDE Archive: PXD013271 (Perez-Riverol et al., 2019).
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